02/10/2025
                                            MR fingerprinting, developed right here at University Hospitals, is transforming care around the world. Donna Plecha, MD, shares how this breakthrough is helping predict chemotherapy response for patients with breast, brain, prostate, lung, and kidney cancers and shaping the future of imaging. 
Learn more about how we are committed to upholding research excellence here or at the link our bio: https://tinyurl.com/37f6e5m5                                        
 
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                                                                                     
                                         
   
   
   
   
     
   
   
  